Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Etodolac
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Etodolac 600mg modified-release tablets
1001010E0AAADAD
|
Etodolac | Etodolac | Musculoskeletal and Joint Diseases | 19,255 |
|
Lodine SR 600mg tablets
1001010E0BBADAD
|
Lodine | Etodolac | Musculoskeletal and Joint Diseases | 1,503 |
|
Etolyn 600mg modified-release tablets
1001010E0BHAAAD
|
Etolyn | Etodolac | Musculoskeletal and Joint Diseases | 171 |
|
Etopan XL 600mg tablets
1001010E0BGAAAD
|
Etopan | Etodolac | Musculoskeletal and Joint Diseases | 127 |
|
Etodolac 300mg capsules
1001010E0AAACAC
|
Etodolac | Etodolac | Musculoskeletal and Joint Diseases | 1 |
|
Ebretin 200mg capsules
1001010E0BDAAAA
|
Ebretin | Etodolac | Musculoskeletal and Joint Diseases | No data available |
|
Ebretin 300mg capsules
1001010E0BDABAC
|
Ebretin | Etodolac | Musculoskeletal and Joint Diseases | No data available |
|
Eccoxolac 300mg capsules
1001010E0BFAAAC
|
Eccoxolac | Etodolac | Musculoskeletal and Joint Diseases | No data available |
|
Etodolac 200mg capsules
1001010E0AAAAAA
|
Etodolac | Etodolac | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.